Table 1.
Baseline characteristics of patients between the 2 groups.
| Variable | Indomethacin Group, N=46 | Prednisolone Group, N=44 |
|---|---|---|
| Age, y, mean (SD) | 66 (16) | 64 (15) |
| Male patients (%) | 39 (85) | 35 (80) |
| History of gout, No. (%) | 45 (98) | 42 (95) |
| Duration of symptoms, d, mean (SD) | 2.3 (0.6) | 2.2 (1.1) |
| Pain score at rest (pretreatment), mm, mean (SD) | 15 (20.8) | 24 (25.2) |
| Pain score with activity (pretreatment), mm, mean (SD) | 74 (20.3) | 78 (19.7) |
| Single joint involved, patients (%) | 45 (98) | 41 (93) |
| >1 Joint involved, No. (%) | 1 (2) | 3 (7) |
| Lower limb involved, No. (%) | 45 (98) | 39 (89) |
| Lower and upper limb involved, No. (%) | 1 (2) | 0 |
| Fever, No. (%) | 8 (17) | 2 (5) |
| Presence of tophus, No. (%) | 2 (4) | 5 (11) |
| Mobility, unable to bear weight, No. (%) | 25 (54) | 29 (66) |
| Admission to observation ward, No. (%) | 3 (7) | 8 (18) |
| Median length of stay in observation ward, h | 23.6 | 23.4 |